Thalassemia is a chronic hemolytic anemia with impaired bead protein production and is a genetic defective disease that does not usually heal on its own.
Moderate thalassemia can be treated by blood transfusion and iron removal.
1. Blood transfusion therapy: moderate thalassemia can reduce anemia symptoms and complications through blood transfusion therapy, which can maintain normal hemoglobin concentration, improve patients’ quality of life and prevent complications.
2. Iron removal treatment: clinically, deferoxamine is often used for treatment, and at the same time, vitamin C and chelating agent should be used in combination, which is conducive to the enhancement of the role of deferoxamine in iron excretion from the urine.
Long-term use of deferoxamine will appear bone development disorders, vision loss and other adverse reactions, in the use of must strictly follow the medical prescription under the guidance of a doctor.
Patients with moderate thalassemia are advised to seek timely medical attention and standardized treatment under the guidance of a doctor.